Biography of Dr. Puneet: Founder & CEO of CureSee- Entrepreneur
Biography of Dr. Puneet:
Dr. Puneet’s journey into the world of healthcare technology
began with a simple desire: to help people see better. As an optometrist and
entrepreneur, he co-founded CureSee, an innovative company focused on treating
amblyopia, commonly known as lazy eye. His mission was inspired by personal
experiences, especially witnessing the challenges faced by patients who
struggled with this condition.
Early Influences
From a young age, Dr. Puneet demonstrated a keen interest in
technology and problem-solving. By the age of 11, he was already teaching
AutoCAD to students, showcasing his passion for innovation. This early
fascination with technology laid the groundwork for his future endeavors in
healthcare, pushing him to find new ways to address age-old problems in the
medical field.
The Birth of CureSee
The idea for CureSee was born during Dr. Puneet’s optometry
internship, where he recognized a significant gap in the treatment options
available for amblyopia. He and his childhood friend, Jatin Kaushik, decided to
create a tech-driven solution that would offer effective therapy to patients of
all ages. This led to the development of CureSee, the world's first AI-based
vision therapy software.
Understanding Amblyopia
Amblyopia affects around 4-5% of the global population,
translating to millions of individuals who experience visual impairment. If
left untreated, it can lead to permanent vision loss, including issues like
depth perception and squinting. Dr. Puneet’s determination to treat this
condition stemmed from the desire to change lives and improve vision for those
affected.
The Technology Behind CureSee
CureSee’s software utilizes advanced artificial intelligence
to provide personalized vision therapy. It adapts to each patient’s progress,
ensuring that the exercises are tailored to their specific needs. This
innovative approach not only makes therapy more effective but also more
engaging for patients, encouraging consistent use.
Recognition and Support
CureSee quickly gained recognition in the healthcare
community for its groundbreaking approach to treating amblyopia. The software
has received multiple accolades, including the prestigious ZS Prize and support
from the Ministry of Electronics and Information Technology in India. These
endorsements helped establish CureSee as a leader in digital health solutions.
A Commitment to Innovation
The founders of CureSee believe in continuous improvement
and innovation. They collaborate with eye specialists and researchers to
enhance the technology and effectiveness of their software. This commitment to
research and development ensures that CureSee remains at the forefront of
vision therapy solutions.
The Shark Tank Opportunity
In 2023, CureSee made waves by appearing on the popular show
Shark Tank India. The founders presented their AI-based vision therapy
software, which generated significant interest among the panel of investors.
The sharks were impressed by the software’s potential to transform amblyopia
treatment, leading to intense competition among them for a stake in the
company.
Securing Investment
CureSee requested ₹40 lakhs for a 5% equity stake, valuing
the company at ₹8 crores. Ultimately, they secured ₹50 lakhs for a 10% stake,
bringing the valuation down to ₹5 crores. This investment not only provided
vital capital for growth but also validated the innovative approach CureSee is
taking in the healthcare sector.
Biography of Dr. Puneet: Founder & CEO of CureSee- Entrepreneur/age/net worth/investor/startup/CureSee story/address amblyopia/healthcare company
Expanding the Reach
With the investment from Shark Tank, CureSee is now poised
for significant expansion. The funds will help enhance their software, expand
their team, and reach more patients across India and beyond. The founders are
excited about the opportunities ahead, which will allow them to help even more
individuals struggling with amblyopia.
A Game-Changing Solution
CureSee’s software is celebrated for making vision therapy
accessible and affordable. Patients can engage in therapy from anywhere, at any
time, using any device. This flexibility is crucial for families, as it allows
them to incorporate therapy into their daily lives without the need for
frequent clinic visits.
Building a Community
The team at CureSee is dedicated to building a community
around vision health. They actively engage with patients, families, and
healthcare professionals to raise awareness about amblyopia and the importance
of early treatment. This community-focused approach not only helps educate the
public but also fosters trust in their innovative solutions.
Future Aspirations
Dr. Puneet envisions a future where CureSee’s technology can
be integrated into routine eye care practices globally. By making effective
treatment for amblyopia widely available, he hopes to significantly reduce the
number of individuals living with this condition. The long-term goal is to
improve the quality of life for millions through better vision.
Celebrating Successes
CureSee has already made a significant impact, helping
thousands of patients improve their vision. The software’s effectiveness has
been widely recognized, and the team celebrates each success story as a
testament to their hard work and dedication. These successes fuel their passion
for continued innovation in vision therapy.
The Road Ahead
Looking to the future, Dr. Puneet and his team at CureSee
are committed to expanding their services and technology. They plan to invest
in further research and development, ensuring that their offerings evolve with
advancements in technology and meet the needs of patients more effectively.
A Lasting Impact
CureSee is more than just a company; it represents a shift
in how we approach vision therapy. Through the innovative use of AI and a
patient-centered approach, CureSee is set to revolutionize the treatment of
amblyopia and empower individuals to achieve better vision. Dr. Puneet’s
journey is a reminder of the power of combining passion with technology to
create lasting change in healthcare.
A timeline for Dr. Puneet’s journey with CureSee:
1990 - Dr. Puneet demonstrates an early interest in
technology and problem-solving.
2001 - At age 11, he teaches AutoCAD, showcasing his passion
for innovation.
2019 - Idea for CureSee emerges during Dr. Puneet’s
optometry internship.
2020 - Dr. Puneet and Jatin Kaushik co-found CureSee to
address amblyopia.
2021 - CureSee develops the world’s first AI-based vision
therapy software.
2022 - CureSee gains recognition in the healthcare community
for its innovative approach.
2023 - The company appears on Shark Tank India, generating
investor interest.
2023 - CureSee secures ₹50 lakhs for a 10% stake, enhancing
its growth potential.
2024 - CureSee expands its reach and enhances its software
with new funding.
Future Aspirations - Dr. Puneet aims to integrate CureSee
into routine eye care globally.